Publication | Closed Access
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
319
Citations
27
References
2019
Year
MedicineMelanomaImmune Checkpoint InhibitorOncologyRadiation OncologyMolecular OncologyBraf-mutant Melanoma
| Year | Citations | |
|---|---|---|
Page 1
Page 1